Abstract

Hepatitis B virus infection is a global public health issue, and there exist many controversies about the antiviral treatment strategies for patients with low-level hepatitis B surface antigen. This article reviews the definition, clinical significance, and current controversial focus of treatment strategies for low-level hepatitis B surface antigen, including treatment timing, drug selection, treatment course determination, and other aspects, while also suggesting future research directions.

乙型肝炎病毒感染是全球性公共卫生问题,低水平乙型肝炎表面抗原患者的抗病毒治疗策略存在诸多争议。该文综述了低水平乙型肝炎表面抗原的定义、临床意义及当前治疗策略的争论焦点,包括治疗时机、药物选择和疗程确定等方面,并对未来研究方向提出建议。.